Principales conclusions et analyse des parts de marché des vaccins contre les infections d'ici 2025-2031
Infectious Vaccines Market Report Analysis
Infectious Vaccines Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- GlaxoSmithKline plc.
- Novartis AG
- Merck and Co, Inc.
- Sanofi
- Pfizer Inc.
- Johnson and Johnson, Services Inc.
- Daiichi Sankyo
- Takeda Pharmaceutical Company Limited
- CSL Limited
Regional Overview
- Amérique du Nord
- Europe
- Asie-Pacifique
- Amérique du Sud et centrale
- Moyen-Orient et Afrique
Market Segmentation
By Type
- vaccins inactivés
- vaccins vivants atténués
- vaccins à ADN et à vecteurs recombinants
- autres
By Maladie
- typhoïde
- tuberculose
- tétanos et diphtérie
- grippe
- hépatite
- poliomyélite
- autres
By Canal de distribution
- hôpitaux et pharmacies de détail
- distribution en ligne
By Géographie
- Amérique du Nord
- Europe
- Asie-Pacifique
- Amérique du Sud et Centrale
Get Free Sample For